Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study.
Van Vlierberghe H, Adler M, Bastens B, Colle I, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Golstein P, Mulkay JP, Van Steenbergen W, Yap P, Nevens F, Denys AM, Brasseur JP. Van Vlierberghe H, et al. Among authors: bastens b. Acta Gastroenterol Belg. 2010 Jan-Mar;73(1):5-11. Acta Gastroenterol Belg. 2010. PMID: 20458844 Free article.
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial.
Van Vlierberghe H, Leroux-Roels G, Adler M, Bourgeois N, Nevens F, Horsmans Y, Brouwer J, Colle I, Delwaide J, Brenard R, Bastens B, Henrion J, de Vries RA, de Galocsy C, Michielsen P, Robaeys G, Bruckers L. Van Vlierberghe H, et al. Among authors: bastens b. J Viral Hepat. 2003 Nov;10(6):460-6. doi: 10.1046/j.1365-2893.2003.00466.x. J Viral Hepat. 2003. PMID: 14633181 Clinical Trial.
Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Delwaide J, Bourgeois N, Gérard C, De Maeght S, Mokaddem F, Wain E, Bastens B, Fevery J, Géhénot M, Le Moine O, Martinet JP, Robaeys G, Servais B, Van Gossum M, Van Vlierberghe H; Belgian Association for the Study of the Liver (BASL). Delwaide J, et al. Among authors: bastens b. Aliment Pharmacol Ther. 2004 Jul 1;20(1):15-22. doi: 10.1111/j.1365-2036.2004.02023.x. Aliment Pharmacol Ther. 2004. PMID: 15225166 Clinical Trial.
Weekly pegylated interferon alpha-2b vs daily interferon a-2b versus standard regimen of interferon a-2b in the treatment of patients with chronic hepatitis C virus infection.
Horsmans Y, Colle I, Van Vlierberghe H, Langlet P, Adler M, Bourgeois N, Brenard R, Michielsen P, Goossens A, Bruckers L; Belgian Assocation for the Study of the Liver. Horsmans Y, et al. Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):293-7. Acta Gastroenterol Belg. 2008. PMID: 19198574 Clinical Trial.
A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients.
Nevens F, Van Vlierberghe H, D'Heygere E, Delwaide J, Adler M, Henrion J, Lenaerts A, Hendlisz A, Michielsen P, Bastens B, Brenard R, Laureys A; BERNAR-1 Study Group. Nevens F, et al. Among authors: bastens b. Acta Gastroenterol Belg. 2010 Apr-Jun;73(2):223-8. Acta Gastroenterol Belg. 2010. PMID: 20690560 Free article. Clinical Trial.
High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry.
Francque S, De Maeght S, Adler M, Deltenre P, de Galocsy C, Orlent H, Van Steenbergen W, Bastens B, Wain E, Langlet P, Lasser L, Verlinden W, Van Marck E, Henrion J; Steering Committee of the Belgian Association for the Study of the Liver. Francque S, et al. Among authors: bastens b. Acta Gastroenterol Belg. 2011 Mar;74(1):9-16. Acta Gastroenterol Belg. 2011. PMID: 21563648 Free article.
Hepatitis C of genotype 2: the role of medical invasive exams.
Putzeys V, Gérard C, Bastens B, Wain E, Bataille C, Defrance P, Belaiche J, Delwaide J, Belaiche J, Delwaide J, de Roover A, Detry O, Gérard C, Honoré P, Maggipinto G, Rentier B, Vaira D; Groupe Liégeois d'Etude des Virus Hépatotropes. Putzeys V, et al. Among authors: bastens b. Acta Gastroenterol Belg. 2011 Jun;74(2):277-80. Acta Gastroenterol Belg. 2011. PMID: 21861311 Free article.
Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs.
Arain A, Bourgeois S, de Galocsy C, Henrion J, Deltenre P, d'Heygere F, George C, Bastens B, Van Overbeke L, Verrando R, Bruckers L, Mathei C, Buntinx F, Van Vlierberghe H, Francque S, Laleman W, Moreno C, Janssens F, Nevens F, Robaeys G. Arain A, et al. Among authors: bastens b. J Med Virol. 2016 Jan;88(1):94-9. doi: 10.1002/jmv.24308. Epub 2015 Jul 21. J Med Virol. 2016. PMID: 26121975
Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.
Moreno C, Deltenre P, Senterre C, Louvet A, Gustot T, Bastens B, Hittelet A, Piquet MA, Laleman W, Orlent H, Lasser L, Sersté T, Starkel P, De Koninck X, Negrin Dastis S, Delwaide J, Colle I, de Galocsy C, Francque S, Langlet P, Putzeys V, Reynaert H, Degré D, Trépo E. Moreno C, et al. Among authors: bastens b. Gastroenterology. 2016 Apr;150(4):903-10.e8. doi: 10.1053/j.gastro.2015.12.038. Epub 2016 Jan 5. Gastroenterology. 2016. PMID: 26764182 Free article. Clinical Trial.
41 results